4189 Efficacy of Venom Immunotherapy Given Every 3 or 4 MONTHS. A DIRECT Prospective COMPARISON with the Conventional REGIMEN

Wednesday, 7 December 2011: 13:30 - 13:45
Cozumel 2 (Cancún Center)

Livio Simioni , Allergy and clin. immunology, int. med. dpt., S. Maria del Prato - Feltre Hospital, Feltre, Italy

Alberto Vianello , Allergy and clin. immunology, int. med. dpt., S. Maria del Prato - Feltre Hospital, Feltre, Italy

Patrizia Bonadonna , Allergy Unit, Verona General Hospital, Verona, Italy

Guido Marcer , Occupational and Environmental Medicine, University of Padua, Padova, Italy

Maurizio Severino , Allergy Clinic, Nuovo Ospedale San Giovanni di Dio - Firenze, Firenze, Italy

Mauro Pagani , Allergy and Oncology Unit, Asola Hospital, Asola, Italy

Luca Morlin , Occupational and Environmental Medicine, University of Padua, Padova, Italy

Mariangiola Crivellaro , Occupational and Environmental Medicine, University of Padua, Padova, Italy

Giovanni Passalacqua, MD , Allergy & Respiratory Diseases, Universita Degli Studi Di Genova, Genoa, Italy

Background: The standard venom immunotherapy involves the administration of the maintenance dose every 4-6 weeks. This regimen may have compliance problem especially in the long term, thus extended intervals have been proposed. We prospectively compared the efficacy of 3- or   4-month extended maintenance dose and the conventional regimen.

Methods: Patients receiving immunotherapy with a single venom were offered the delayed maintenance dose, and were then followed-up for field re-stings. Only the re-stings by the insect for which the patients received immunotherapy were considered. A matched group of patients receiving the conventional maintenance were used for comparison, by univariate and multivariate analysis.

Results: Fifty-two patients (44 male, 8 female, mean age 52 years) were certainly re-stung on 113 occasions by the insect for which they were receiving immunotherapy. 90  re-stings occurred during the 3- month maintenance, and 23 during the 4-month maintenance. The control group, on conventional protocol with one single venom, included 103 patients (79 male, 24 female, mean age 41 years) certainly re-stung on 160 occasions by the specific insect. The rate of re-sting without reaction was 97% in the delayed maintenance and 82% in the conventional group with a significant difference in favour of the former (p= 0.01). None of the variables considered resulted predictive for systemic reactions by logistic regression analysis

Conclusions: The delayed maintenance dose approach is al least as effective and safe as the conventional one. The 4-month maintenance seems to be the best option in term of convenience and economic save.